Your browser doesn't support javascript.
loading
SOX9 and HMGB3 co-operatively transactivate NANOG and promote prostate cancer progression.
Xu, Yunyi; Xu, Miao; Li, Xinglan; Weng, Xin; Su, Zhengzheng; Zhang, Mengni; Tan, Junya; Zeng, Hao; Li, Xun; Nie, Ling; Gong, Jing; Chen, Ni; Chen, Xueqin; Zhou, Qiao.
Afiliación
  • Xu Y; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Xu M; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Li X; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Weng X; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Su Z; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang M; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Tan J; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zeng H; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.
  • Li X; Department of Ophthalmology and Research Laboratory of Ophthalmology and Vision Sciences, West China Hospital, Sichuan University, Chengdu, China.
  • Nie L; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Gong J; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Chen N; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Chen X; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Zhou Q; Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Prostate ; 83(5): 440-453, 2023 04.
Article en En | MEDLINE | ID: mdl-36541373
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteína HMGB3 / Factor de Transcripción SOX9 / Proteína Homeótica Nanog Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Prostate Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteína HMGB3 / Factor de Transcripción SOX9 / Proteína Homeótica Nanog Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Prostate Año: 2023 Tipo del documento: Article País de afiliación: China